Contributions
Abstract: EP1366
Type: ePoster
Abstract Category: Clinical aspects of MS - Epidemiology
Introduction: Deprivation has been associated with a number of adverse health outcomes. For Multiple Sclerosis (MS) in Scotland, there is a target time of < 10 working days (14 days) between diagnosis and contact with an MS Specialist Nurse. We explored the impact of deprivation on waiting time to see an MS specialist nurse.
Background: The Scottish Index of Multiple Deprivation 2012 (SIMD) is a tool for identifying relative deprivation across geographical areas in Scotland. It creates an aggregate measure of deprivation for 6505 individual areas. Areas are ranked from most deprived to least deprived and split into 20 vigintiles (1= 5% most deprived to 20 = 5% least deprived). The Scottish MS Register (SMSR) is a register of new diagnosis of MS occurring after 1/1/2010. Data recorded in SMSIR include location data, date of date of diagnosis, date of contact with MS nurses.
Methods: Data on newly diagnosed cases of MS for the last 5 years (2010-15) were obtained from the SMSR and were collated with SIMD to assign each MS case with a deprivation vigintile. Cases were placed into 2 groups (High deprivation = Vigintiles 1-10, Low Deprivation = Vigintiles 11-20) and average wait (days) to see an MS nurse was calculated for each group. This was then split into < 14 days or >14 days. Fisher"s test was used to calculate the significance of the difference between groups. Statistical Significance was taken as p< 0.05.
Results: In the high deprivation group (n=1165), 587 patients (50.4%) were seen before 14 days vs 718 patients (54.4%) for the low deprivation group (n=1320). The difference was significant (p=0.049, OR 0.85, 95% CI 0.727-1).
Conclusion: Patients from more deprived areas are more likely to wait longer than the government target of being seen by MS nurses within 10 working days from diagnosis. Deprivation is seen to have a negative impact on engagement with MS Services.
Disclosure: Dr James McDonald; Nothing to disclose
Ms Hazel Dodds: Nothing to disclose
Mr Martin O´Neill: Nothing to disclose
Dr Belinda Weller: Nothing to disclose
Dr Jonathan O´Riordan: I have been principal Investigator in trials sponsored by Biogen, GW Pharma, Novartis, Genzyme (a Sanofi company), Teva and Bayer. I have been a guest of Novartis, Biogen and Teva to attend various meetings and conferences. I have acted as consultant in advisory boards arranged by Biogen, Novartis and Genzyme (a Sanofi company). I hold shares < £10,000 in GW Pharma.
Abstract: EP1366
Type: ePoster
Abstract Category: Clinical aspects of MS - Epidemiology
Introduction: Deprivation has been associated with a number of adverse health outcomes. For Multiple Sclerosis (MS) in Scotland, there is a target time of < 10 working days (14 days) between diagnosis and contact with an MS Specialist Nurse. We explored the impact of deprivation on waiting time to see an MS specialist nurse.
Background: The Scottish Index of Multiple Deprivation 2012 (SIMD) is a tool for identifying relative deprivation across geographical areas in Scotland. It creates an aggregate measure of deprivation for 6505 individual areas. Areas are ranked from most deprived to least deprived and split into 20 vigintiles (1= 5% most deprived to 20 = 5% least deprived). The Scottish MS Register (SMSR) is a register of new diagnosis of MS occurring after 1/1/2010. Data recorded in SMSIR include location data, date of date of diagnosis, date of contact with MS nurses.
Methods: Data on newly diagnosed cases of MS for the last 5 years (2010-15) were obtained from the SMSR and were collated with SIMD to assign each MS case with a deprivation vigintile. Cases were placed into 2 groups (High deprivation = Vigintiles 1-10, Low Deprivation = Vigintiles 11-20) and average wait (days) to see an MS nurse was calculated for each group. This was then split into < 14 days or >14 days. Fisher"s test was used to calculate the significance of the difference between groups. Statistical Significance was taken as p< 0.05.
Results: In the high deprivation group (n=1165), 587 patients (50.4%) were seen before 14 days vs 718 patients (54.4%) for the low deprivation group (n=1320). The difference was significant (p=0.049, OR 0.85, 95% CI 0.727-1).
Conclusion: Patients from more deprived areas are more likely to wait longer than the government target of being seen by MS nurses within 10 working days from diagnosis. Deprivation is seen to have a negative impact on engagement with MS Services.
Disclosure: Dr James McDonald; Nothing to disclose
Ms Hazel Dodds: Nothing to disclose
Mr Martin O´Neill: Nothing to disclose
Dr Belinda Weller: Nothing to disclose
Dr Jonathan O´Riordan: I have been principal Investigator in trials sponsored by Biogen, GW Pharma, Novartis, Genzyme (a Sanofi company), Teva and Bayer. I have been a guest of Novartis, Biogen and Teva to attend various meetings and conferences. I have acted as consultant in advisory boards arranged by Biogen, Novartis and Genzyme (a Sanofi company). I hold shares < £10,000 in GW Pharma.